GH treatment in adults with chronic liver disease: A randomized, double-blind, placebo-controlled, cross-over study

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 6, 2002, Pages 2751-2759

  Wallace, Jennifer D ^a   Abbott Johnson, Winsome J ^b   Crawford, Darrell H G ^b   Barnard, Ross ^b   Potter, Julia M ^a   Cuneo, Ross C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE;

ADULT; ALCOHOL METABOLISM; ARTICLE; ASCITES; BASAL METABOLIC RATE; BILIARY CIRRHOSIS; CATABOLISM; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EDEMA; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS NON A NON B NON C; HORMONAL THERAPY; HORMONE RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPEDANCE; INSULIN RESISTANCE; LIPID OXIDATION; LIVER BIOPSY; LIVER CELL DAMAGE; LONG TERM CARE; MALE; NATRIURESIS; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL; TOTAL BODY WATER;

NON-A, NON-B HEPATITIS VIRUS;

EID: 0036086341     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.6.8548     Document Type: Article

References (62)

1. Malnutrition in children with chronic liver disease accepted for liver transplantation: Clinical profile and effect on outcome
2. Pathogenesis and assessment of malnutrition in liver disease
3. Nutritional support in children with end-stage liver disease: A randomized cross-over trial of a branched-chain amino acid supplement
4. Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease
5. Insulin-like growth factor 1 and growth hormone in chronic liver disease
6. Normal growth and development in the absence of hepatic insulin-like growth factor I
7. Growth hormone stimulates skeletal muscle protein synthesis and antagonizes insulin's antiproteolytic action in humans
8. Role of insulin-like growth factors and growth hormone in reversing catabolic states
9. Insulin-like growth factors and their binding proteins: Biological actions
10. Effects of growth hormone on glucose and lipid metabolism
11. Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: A controlled experimental study
12. Growth hormone treatment in adults with liver cirrhosis
13. Total body potassium in cystic fibrosis
14. Distribution of body water in patients with cirrhosis: The effect of liver transplantation
15. Validation of tetrapolar bioelectrical impedance method to assess human body composition
16. Estimation of body fluid volumes using tetrapolar bioelectrical impedance measurements
17. The assessment of the amount of fat in the human body from measurements of skinfold thicknesses
18. Measurement reliability and reactivity using repeated measurements of resting energy expenditure with a face mask, mouthpiece, and ventilated canopy
19. The theoretical basis of indirect calorimetry: Review
20. Calculation of substrate oxidation rates in vivo from gaseous exchange
21. A quick, sensitive high-performance liquid chromatography assay for monoethylglycinexylidide and lignocaine in serum/plasma using solid phase extraction
22. Use of monoethlyglycinexylidide as a liver function test in the liver transplant recipient
23. Transection of the oesophagus for bleeding oesophageal varices
24. Growth hormone-binding protein in normal and pathological gestation: Correlations with maternal diabetes and fetal growth
25. Circulating levels of insulin-like growth factors increase and molecular forms of their serum binding proteins change with human pregnancy
26. Developmental changes in growth hormone, insulin-like growth factors (IGF-1 and IGF-II) and IGF-binding proteins in plasma of growing pigs
27. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma
28. Circulating levels and molecular distribution of the acid-labile (a) suburdt of the high molecular weight insulin-like growth factor-binding protein complex in normal subjects
29. Grip and arm strength in males and females, age 10 to 69
30. Absence of growth-hormone receptor in hepatocellular carcinoma and cirrhotic liver
31. Cirrhotic liver expresses low levels of the full-length and truncated growth hormone receptors
32. Human growth hormone replacement therapy: Pharmacological and clinical aspects
33. Short-term effect of recombinant growth hormone in patients with alcoholic cirrhosis
34. Growth hormone therapy in patients with cirrhosis: A pilot study of efficacy and safety
35. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex
36. Cellular localization and hormonal regulation of biosynthesis of insulin-like growth factor binding proteins and of the acid-labile subunit within rat liver
37. Hormonal and nutritional regulation of IGF-I and its binding proteins
38. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis
39. Growth hormone receptor and serum binding protein: Purification, cloning and expression
40. The serum growth hormone binding protein: Pregnant with possibilities
41. Serum growth hormone-binding protein, insulin-like growth factor-I, and growth hormone in patients with liver cirrhosis
42. Different modes of growth hormone (GH) administration do not change GH binding protein activity in man
43. Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age
44. Body composition analysis in liver cirrhosis. The measurement of body fat by dual energy x-ray absorptiometry in comparison to skinfold anthropometry, bioelectrical impedance and total body potassium
45. Basal metabolic rate in adults with growth hormone deficiency and in patients with acromegaly: Relationship with lean body mass, plasma insulin level and leucocyte sodium pump activity
46. Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength
47. The syndrome of growth hormone deficiency in adults. Physiological and clinical aspects
48. The hormonal control of protein metabolism
49. The effects of growth hormone and insulin-like growth factors I and II on glutamine metabolism by skeletal muscle of the rat in vitro
50. The effect of growth hormone and insulin-like growth factors I and II on glutamine metabolism by skeletal muscle of the rat in vitro
51. Quantitative aspects of glucose and glutamine metabolism by intestinal cells
52. Regulation of growth hormone (GH) secretion by different glutamate receptor subtypes in the rat
53. Disordered energy and protein metabolism in liver disease
54. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency
55. +-deficient rats
56. Growth hormone administration stimulates energy expenditure and extra-thyroidal conversion of thyroxine to triiodothyronine in a dose-dependent mariner and suppresses circadian thyrotrophin levels: Studies in GH-deficient adults
57. Glucose metabolism and liver cirrhosis
58. Insulin-like growth factor-binding protein-1: A role in glucose counterregulation?
59. Evidence for a role for insulin and growth hormone in overnight regulation of 3-hydroxybutyrate in normal and diabetic adolescents
60. Growth hormone and bone
61. Growth hormone, the insulin-like growth factor system, and the kidney